Mabpharm Limited (02181)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Cen Jialin | 10-Jul-24 | NED | |||
| Guo Jianjun | 01-Jun-18 | 28-Nov-23 | NED | Due to age concern | |
| Guo Liang Zhong | 10-Aug-18 | INED | |||
| Guo Liangzhong | 31-May-19 | INED | |||
| Hou Sheng | 28-Nov-23 | ED | |||
| Jiao Shuge | 20-Jul-18 | Ch, NED | |||
| Leung Louis Ho Ming | 17-Jun-22 | INED | |||
| Li Jing | 20-Jul-18 | 28-Nov-23 | ED | In order to devote more time to her other personal commitments | |
| Li Yun Feng | 20-Jul-18 | ED | |||
| Li Yunfeng | 20-Jul-18 | FD | |||
| CoSec | |||||
| 10-Jul-24 | CFO | Li will be appointed as a vice president of the Company and he no longer holds the position of chief financial officer | |||
| Liu Lin Qing | 10-Aug-18 | 17-Jun-22 | INED | ||
| Liu Linqing | 31-May-19 | 17-Jun-22 | INED | ||
| Qian Wei Zhu | 20-Jul-18 | 28-Oct-20 | ED | ||
| Qian Weizhu | 31-Oct-25 | MbNC | |||
| 10-Jul-24 | ED | ||||
| 28-Nov-23 | 10-Jul-24 | NED | |||
| 20-Jul-18 | 28-Oct-20 | CEO | |||
| Tao Jing | 28-Oct-20 | ED | |||
| 31-Oct-25 | MbNC | Ceased to be a member of the Nomination Committee as part of changes in response to amendments to the Listing Rules and Corporate Governance Code. | |||
| Tao Qian | 10-Jul-24 | INED | |||
| Tsang Ho Yin | CoSec | ||||
| Wang Hao | 28-Oct-20 | CEO | |||
| 20-Jul-18 | 28-Oct-20 | ED | |||
| Zhang Yan Yun | 10-Aug-18 | INED | |||
| Zhang Yanyun | 31-Oct-25 | INED | |||
| 31-May-19 | INED |